These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8196274)

  • 1. COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; Weber M; Netzer KO; Sun MJ; Neilson EG; Hudson BG
    Kidney Int; 1994 Mar; 45(3):721-6. PubMed ID: 8196274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
    Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
    Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of post-transplant anti-alpha 5 (IV) collagen alloantibodies in X-linked Alport syndrome.
    Dehan P; Van den Heuvel LP; Smeets HJ; Tryggvason K; Foidart JM
    Nephrol Dial Transplant; 1996 Oct; 11(10):1983-8. PubMed ID: 8918711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.
    Kalluri R; Torre A; Shield CF; Zamborsky ED; Werner MC; Suchin E; Wolf G; Helmchen UM; van den Heuvel LP; Grossman R; Aradhye S; Neilson EG
    Transplantation; 2000 Feb; 69(4):679-83. PubMed ID: 10708133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quaternary epitopes of α345(IV) collagen initiate Alport post-transplant anti-GBM nephritis.
    Olaru F; Luo W; Wang XP; Ge L; Hertz JM; Kashtan CE; Sado Y; Segal Y; Hudson BG; Borza DB
    J Am Soc Nephrol; 2013 May; 24(6):889-95. PubMed ID: 23620401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis.
    Ding J; Zhou J; Tryggvason K; Kashtan CE
    J Am Soc Nephrol; 1994 Aug; 5(2):161-8. PubMed ID: 7993995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
    Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
    J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the alpha 5 chain of type IV collagen.
    Ding J; Kashtan CE; Fan WW; Kleppel MM; Sun MJ; Kalluri R; Neilson EG; Michael AF
    Kidney Int; 1994 May; 45(5):1504-6. PubMed ID: 8072264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain.
    Kang JS; Kashtan CE; Turner AN; Heidet L; Hudson BG; Borza DB
    J Biol Chem; 2007 Apr; 282(14):10670-7. PubMed ID: 17293596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retransplantation in Alport post-transplant anti-GBM disease.
    Browne G; Brown PA; Tomson CR; Fleming S; Allen A; Herriot R; Pusey CD; Rees AJ; Turner AN
    Kidney Int; 2004 Feb; 65(2):675-81. PubMed ID: 14717941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of anti-GBM nephritis in rats by recombinant alpha 3(IV)NC1 and alpha 4(IV)NC1 of type IV collagen.
    Sado Y; Boutaud A; Kagawa M; Naito I; Ninomiya Y; Hudson BG
    Kidney Int; 1998 Mar; 53(3):664-71. PubMed ID: 9507212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
    Kashtan CE
    Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
    Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
    Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetics of Alport syndrome].
    Yamazaki H; Saito A; Nakagawa Y; Arakawa M
    Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis.
    Borza DB
    Nephron Exp Nephrol; 2007; 106(2):e37-43. PubMed ID: 17570938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome.
    Kashtan CE; Butkowski RJ; Kleppel MM; First MR; Michael AF
    J Lab Clin Med; 1990 Oct; 116(4):508-15. PubMed ID: 2212860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
    Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
    J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.